Search clinical trials for: Etoricoxib

Total 113 results

Guangdong Provincial Hospital of Traditional Chinese...

Recruiting

Immediate Analgesic Effects of Cheek Acupuncture for Acute Gouty Arthritis (CAAGA)

Acute Pain | Acupuncture | Acute Gout Arthritis

China
Dow University of Health Sciences

Not yet recruiting

Comparison of the Anti-Inflammatory Efficacy of Preemptive Dexamethasone and Etoricoxib

Effect of Drug
Gadjah Mada University

Recruiting

Adductor Canal Block in Outpatient Clinic for Pain Control After Knee Arthroplasty (ACB)

Acute Pain | Total Knee Arthroplasty

Indonesia
Pharmtechnology LLC
ClinPharmInvest, LLC

Not yet recruiting

Bioequivalence Study of Two Formulations of Etoricoxib Tablets 120 mg in Healthy Volunteers Under Fasting Conditions

Bioequivalence

Russian Federation
Shanghai Yueyang Integrated Medicine Hospital

Not yet recruiting

Oral Huzhang Granules for Acute Gouty Arthritis

Gouty Arthritis
Rambam Health Care Campus

Completed

Biomarkers for Prediction of Analgesic Efficacy in Knee OA.

Knee, Osteoarthritis (OA) | Biomarkers for Prediction of OA Treatment Efficacy

Israel
Eurofarma Laboratorios S.A.

Withdrawn

Fixed-dose Combination of Etoricoxib + Cyclobenzaprine for Pain Relief After Third Molar Extraction in Brazil (BENCOX)

Third Molar Extraction

Brazil
Laboratorios Liomont
Infinite Clinical Research, S.A. de C.V.

Completed

Efficacy and Safety of Etoricoxib-tramadol Tablet in Acute Postoperative Pain

Postoperative Pain | Acute Pain

Mexico
University of Belgrade

Completed

Effect of Preemptive Etoricoxib and Dexamethasone on Wound Healing and Clinical Parameters After Third Molar Surgery

Surgical Wound | Post Operative Pain

Serbia
Laboratorios Silanes S.A. de C.V.

Completed

Comparative Bioavailability Study Between Etoricoxib and Tramadol, Administered Individually or in Combination

Healthy

Mexico
Future University in Egypt

Completed

Bioequivalence Study of Etoricoxib in Healthy Adult Subjects Under Fasting Condition

Healthy Subjects

Egypt
Laboratorios Silanes S.A. de C.V.

Completed

Efficacy and Safety of Fixed-dose Combination of Etoricoxib/Tramadol vs Acetaminophen/Tramadol for Acute Low Back Pain

Acute Low Back Pain

Mexico
Anne Margarita Dyrhol Riise
University of Oslo; Haukeland University Hospital; Statens Serum Institut

Completed

Therapeutic Vaccination and Immune Modulation - New Treatment Strategies for the MDR Tuberculosis Pandemic (TBCOX2)

Tuberculosis

Norway
Organon and Co

Completed

A Study to Assess the Safety and Efficacy of an Investigational Drug in Patients With Osteoarthritis (0663-071)(COMPLETED)

Osteoarthritis
Organon and Co

Completed

Etoricoxib vs. Diclofenac in OA (0663-805)(COMPLETED)

Osteoarthritis
Organon and Co

Completed

Post-authorization Safety Study of Etoricoxib and Other Anti-inflammatory Therapies in European Patients With Ankylosing Spondylitis (MK-0663-163)

Ankylosing Spondylitis
Organon and Co

Completed

Etoricoxib in the Treatment of Osteoarthritis (MK-0663-007)

Osteoarthritis
Organon and Co

Completed

Effect of Etoricoxib to Treat Chronic Low Back Pain (0663-042)

Recurrent Low Back Pain
Organon and Co

Completed

A Study to Evaluate the Safety of an Investigational Drug (Etoricoxib) in Patients With Osteoarthritis (OA) or Rheumatoid Arthritis (RA)(0663-066)

Rheumatoid Arthritis,Osteoarthritis
Organon and Co

Completed

Effect of Etoricoxib to Treat Chronic Low Back Pain (0663-041)

Recurrent Low Back Pain
Organon and Co

Withdrawn

A Study of Etoricoxib in Participants With Osteoarthritis Not Responding to Analgesic Drugs (MK-0663-142) (RESPOND-EUROPE)

Osteoarthritis
Organon and Co

Completed

Safety of Etoricoxib (MK-0663) in Patients With Spondyloarthropathy (SpA)/Ankylosing Spondylitis (AS) in Sweden (EP07013.013.11.082)

Spondylarthropathies; Spondylitis, Ankylosing
Organon and Co

Completed

Etoricoxib Prescribing Patterns and Adverse Events of Interest in Primary Care in the United Kingdom (MK-0663-162 AM1)

Arthritis | Osteoarthritis | Rheumatoid Arthritis | Gout | Ankylosing Spondylitis
Organon and Co

Withdrawn

Safety and Efficacy of an Investigational Drug Versus Placebo in the Treatment of Cancer Pain (0663-083)

Bone Neoplasms
Organon and Co

Completed

A Study of MK0663 and an Approved Drug in the Treatment of Osteoarthritis (0663-077)(COMPLETED)

Osteoarthritis
Organon and Co

Completed

A Study to Assess Etoricoxib Versus Diclofenac in Chinese Patients With Osteoarthritis of the Knee or Hip (0663-080)(COMPLETED)

Osteoarthritis
Organon and Co

Completed

Investigational Drug Versus an Approved Drug in Patients With Osteoarthritis (0663-061)(COMPLETED)

Osteoarthritis
Organon and Co

Completed

An Investigational Drug Study in the Treatment of Primary Dysmenorrhea (0663-064)

Dysmenorrhea
Organon and Co

Completed

Analgesic Treatment Mediated by Arcoxia (0663-093)

Pain
Organon and Co

Completed

Investigational Drug Versus an Approved Drug in Patients With Rheumatoid Arthritis (0663-072)

Rheumatoid Arthritis
Organon and Co

Completed

Quality of Life With Arcoxia in Women With Dysmenorrhea (0663-094)

Pain
Organon and Co

Completed

An Investigational Drug in Patients With Osteoarthritis (0663-073)

Osteoarthritis
Organon and Co

Completed

A Study Evaluating the Effect of Etoricoxib and Indomethacin in the Treatment of Acute Gout (0663-081)(COMPLETED)

Acute Gout
Organon and Co

Completed

A Study of MK0663 and an Approved Drug in the Treatment of Osteoarthritis (0663-076)(COMPLETED)

Osteoarthritis
Organon and Co

Completed

Study of MK0663 in Patients With Chronic Low Back Pain (0663-806)(COMPLETED)

Chronic Low Back Pain
Guangdong Provincial People's Hospital

Completed

Prevention of Taxane-associated Acute Pain Syndrome With Etoricoxib

Pain Syndrome

China
Organon and Co

Completed

Study to Assess the Safety and Efficacy of Etoricoxib Versus Ibuprofen in the Treatment of Dysmenorrhea (MK-0663-145 AM1)

Dysmenorrhea
Organon and Co

Completed

Safety and Efficacy of Etoricoxib 30 mg Versus Celecoxib 200 mg in Korean Participants With Osteoarthritis

Osteoarthritis of the Knee
Organon and Co

Completed

The Single Dose Pharmacokinetics of Two and Proof of Efficacy of One New Etoricoxib Gel Formulation in Participants With Osteoarthritis (MK-0663-168)

Osteoarthritis Pain
Organon and Co

Completed

Study of the Bioequivalence of the 20% and 30% Etoricoxib Tablet Formulations (0663-070)

Pain
Organon and Co

Completed

Rheumatoid Arthritis Dose Ranging Study (0663-086)(COMPLETED)

Rheumatoid Arthritis
Organon and Co

Completed

Patient-Reported Effectiveness and Safety of Etoricoxib in Osteoarthritis (OA)(0663-113)

Pain
Organon and Co

Completed

A Study of the Patterns of Use of Etoricoxib in France (MK-0663-148) (COXIBUS)

Osteoarthritis
Organon and Co

Completed

A Two-Part 26-Week Study of Etoricoxib as Treatment for Ankylosing Spondylitis (AS) (MK-0663-108)

Spondylitis, Ankylosing
Organon and Co

Completed

Study of MK-0663/Etoricoxib in Postorthopedic Knee Replacement Surgery Pain (MK-0663-098)

Pain, Postoperative
Organon and Co

Completed

A Study to Asses the Effect of MK0663 in the Treatment of Patients With Postoperative Dental Pain (0663-092)

Postoperative Dental Pain
Organon and Co

Completed

A Two-Part, 12-Week Study of Etoricoxib as a Treatment for Rheumatoid Arthritis (RA) (MK-0663-107)

Arthritis, Rheumatoid
Organon and Co

Completed

A Study of MK0663/Etoricoxib for Post-Abdominal Hysterectomy Surgery Pain (0663-097)(COMPLETED)

Acute Pain Following a Total Abdominal Hysterectomy
Woerwag Pharma LLC

Completed

Milgamma® and Milgamma® Compositum Step-therapy in Patients With Acute Non-specific Low Back Pain Receiving Modern NSAID

Acute Non-specific Low Back Pain

Russian Federation
Darnitsa Pharmaceutical Company
Anapharm Bioanalytics

Completed

Bioequivalence Study of Test and Reference 120 mg Etoricoxib Film-coated Tablets in Healthy Volunteers

Healthy Subjects | Bioequivalence

Turkey

3

Subscribe